Are older adults more vulnerable to scams?
In The Conversation, Drs. Natalie Ebner and Didem Pehlivanoglu discuss the factors that shape vulnerability to scams in older adults.
In The Conversation, Drs. Natalie Ebner and Didem Pehlivanoglu discuss the factors that shape vulnerability to scams in older adults.
In The Conversation Drs. John Ligon and Christina von Roemeling discuss new paper they co-authored in the journal Cell.
In The Conversation, Dr. Matthew Farrer discusses his team's new paper published in The Lancet Neurology.
In The Conversation, Dr. Giridhar Kalamangalam tells the story of the game-changing medical test that measures brain electrical activity.
In The Conversation, Dr. Andrea Merchak explains her team’s research into probiotics and whether microscopic organisms in the gut may play a role in regulating stress.
In The Conversation, Drs. Brian Ho and Ronald Cohen explain the key findings in a recent study.
In The Conversation, UF neuroscientist Dr. Steven DeKosky explains new discoveries with treatment implications.
In The Conversation, UF neuroscientist Dr. Habibeh Khoshbouei explains the science behind the controversial ADHD drug.
In The Conversation, UF neuropsychologist Dr. John B. Williamson explains when depression becomes a crisis.
In The Conversation, Dr. Gary Reisfield explains what affects the opiate content of poppy seeds and how they could influence drug tests.